Corgentech to Host Webcast Conference Call on Wednesday, May 24, 2006
23 5월 2006 - 4:00AM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., May 22 /PRNewswire-FirstCall/ --
Corgentech Inc. (NASDAQ:CGTK) will host a webcast conference call
on Wednesday, May 24, 2006 at 4:30 p.m. Eastern Time. Members of
Corgentech's management team plan to provide additional detail
about the commercial opportunity for its lead pain management
product candidates: 3268, a fast-acting topical local anesthetic
for which the company plans to submit a New Drug Application with
the U.S. Food and Drug Administration in the summer, and 4975, a
novel, long-acting, non-opioid for treating moderate-to-severe
pain. Interested parties can listen to the live audio webcast and
view the accompanying slide presentation, or the subsequent
archived recording, by logging on to http://www.corgentech.com/ and
going to the Investor Information page. Please connect to
Corgentech's website several minutes prior to the start of the
conference call to ensure adequate time for any software download
that may be necessary. For those unable to participate via the
Internet, a 24-hour replay will be available for seven days after
the call by calling 1(800) 642-1687, or (706) 645-9291 for
international callers, and giving the following pass code: 9649306.
About Corgentech Corgentech is a late-stage biopharmaceutical
company that seeks to be the leader in the development and
commercialization of novel therapeutic treatments for pain. The
company has four drug candidates in clinical development for
multiple potential indications, the most advanced of which, 3268,
has completed Phase 3 clinical trials. To reflect the company's
core focus on novel pain management therapies, the board of
directors recently voted to change the company name to Anesiva. If
approved by stockholders at the annual meeting on June 21, 2006,
the name change will become effective immediately thereafter.
Corgentech is based in South San Francisco, CA. Forward Looking
Statements This press release includes "forward-looking statements"
within the meaning of the safe harbor provisions of the United
States Private Securities Litigation Reform Act of 1995. Words such
as "expect," "estimate," "project," "budget," "forecast,"
"anticipate," "intend," "plan," "may," "will," "could," "should,"
"believes," "predicts," "potential," "continue," and similar
expressions are intended to identify such forward-looking
statements. Forward- looking statements in this press release
include, without limitation, projected timing of FDA filings and
clinical data announcements and other matters that involve known
and unknown risks, uncertainties and other factors that may cause
actual results, levels of activity, performance or achievements to
differ materially from results expressed or implied by this press
release. Such risk factors include, among others: whether
Corgentech can successfully develop new products and the degree to
which these gain market acceptance. Actual results may differ
materially from those contained in the forward- looking statements
in this press release. Additional information concerning these and
other risk factors is contained in Corgentech's quarterly report on
Form 10-Q for the quarter ended March 31, 2006. Corgentech
undertakes no obligation and does not intend to update these
forward-looking statements to reflect events or circumstances
occurring after this press release. You are cautioned not to place
undue reliance on these forward-looking statements, which speak
only as of the date of this press release. All forward-looking
statements are qualified in their entirety by this cautionary
statement. DATASOURCE: Corgentech Inc. CONTACT: Richard Powers,
Chief Financial Officer of Corgentech Inc., +1-650-624-9600, or ;
or Daryl Messinger, Media of WeissComm Partners, +1-415-999-2361,
or , for Corgentech Inc. Web site: http://www.corgentech.com/
Copyright
Corgentech (NASDAQ:CGTK)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Corgentech (NASDAQ:CGTK)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024